[White Paper] Can mRNA Disrupt The Biopharma Industry? 본문 목록 이전글 [포스터] Part 1 – The Need for Speed and Safety 다음글 [어플리케이션 노트] Control and scale-up of a microcarrier-based viral vaccine process using BioPAT ® ViaMass for inline viable cell de